Investigating immune and non-immune cellular profiles in recurrent respiratory papillomatosis by multi-omics

Zijie Niu; Yang Xiao; Yiran Li; Sihan Zhou; Meiyu Liu; Fangyuan Li; Yaran Zhang; Jun Wang; Xunyao Wu

doi:10.1002/ctm2.1570

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (3) : e1570 DOI: 10.1002/ctm2.1570

LETTER TO THE JOURNAL

Investigating immune and non-immune cellular profiles in recurrent respiratory papillomatosis by multi-omics

Zijie Niu ¹^,²
, Yang Xiao ¹^,²
, Yiran Li ³^,⁴
, Sihan Zhou ¹^,²
, Meiyu Liu ³
, Fangyuan Li ³
, Yaran Zhang ³
, Jun Wang ¹^,²^,^†
, Xunyao Wu ³^,⁴^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Zijie Niu, Yang Xiao, Yiran Li, Sihan Zhou, Meiyu Liu, Fangyuan Li, Yaran Zhang, Jun Wang, Xunyao Wu. Investigating immune and non-immune cellular profiles in recurrent respiratory papillomatosis by multi-omics. Clinical and Translational Medicine, 2024, 14(3): e1570 DOI:10.1002/ctm2.1570

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Lépine C, Klein P, Voron T, et al. Histological severity risk factors identification in juvenile-onset recurrent respiratory papillomatosis: how immunohistochemistry and AI algorithms can help? Front Oncol. 2021;11:596499.

[2]	Benedict JJ, Derkay CS. Recurrent respiratory papillomatosis: a 2020 perspective. Laryngoscope Investig Otolaryngol. 2021;6(2):340-345.

[3]	Kansy BA, Concha-Benavente F, Srivastava RM, et al. PD-1 status in CD8(+) T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer. Cancer Res. 2017;77(22):6353-6364.

[4]	Gameiro SF, Ghasemi F, Barrett JW, et al. Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy. Oncoimmunology. 2018;7(10):e1498439.

[5]	Feng Q, Wei H, Morihara J, et al. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. Gynecol Oncol. 2012;127(2):412-419.

[6]	Berti FCB. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma. Cytokine Growth Factor Rev. 2017;34:1-13.

[7]	Osako Y, Seki N, Kita Y, et al. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma. Int J Oncol. 2016;49(6):2255-2264.

[8]	Kudo Y, Iizuka S, Yoshida M, et al. Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis. J Biol Chem. 2012;287(46):38716-38728.

[9]	García-Irigoyen O, Carotti S, Uriarte I. Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis. Hepatology. 2015;62(1):166-178.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.